The costs of dozens of cancer drugs were about 2.3 times higher in the U.S. than in Europe even though they had similar clinical benefits, according to a study cited by STAT.
Oncology
Researchers at Danville, Pa.-based Geisinger have successfully used a blood test to diagnose presymptomatic cancer patients for the first time, according to a study published in Science.
Grisel Fernandez-Bravo, DNP, CEO of Memorial Hospital Miramar (Fla.), has had to find new ways to manage operations after treatment for her cancer diagnosis left her immunocompromised and susceptible to COVID-19.
New research shows that cancer patients who contract COVID-19 are nearly three times more likely to die that COVID-19 patients who do not have cancer, a new study shows.
Memphis, Tenn.-based St. Jude Children's Research Hospital partnered with the International Society of Paediatric Oncology to launch a global COVID-19 data registry and resource center for pediatric cancer.
AstraZeneca will start a clinical trial to see if its cancer drug Calquence can suppress the excessive immune response COVID-19 triggers in some patients, the drugmaker said April 14.
U.S. cancer patients experience differences in survival rates in accordance with their race or ethnic group, a study published in JAMA Network Open shows.
With federal and state governments loosening restrictions on telemedicine due to the coronavirus pandemic, hospitals such as Tampa, Fla.-based Moffitt Cancer Center have reported steep increases in virtual visits with patients.
Cancer patients at a hospital in Wuhan, China, were twice as likely to be diagnosed with COVID-19 as the general population, suggesting cancer patients may face a higher risk during the pandemic, according to a study published in JAMA Oncology.
